RHÃN-KLINIKUM AG 30.01.2013 12:00 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Notification according to section 26 para. 1 WpHG JPMorgan Chase & Co, New York, USA, notified us on 29 January 2013 pursuant to section 21 para. 1 WpHG of the following: On 24 January 2013 JPMorgan Chase & Co exceeded the threshold of 3% of the voting rights in RHÃN-KLINIKUM AG, Schlossplatz 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date JPMorgan Chase & Co held 4.27% of the voting rights in RHÃN-KLINIKUM AG arising from 5,895,660 voting rights. These voting rights in RHÃN-KLINIKUM AG are completely attributed to JPMorgan Chase & Co pursuant to sec. 22 para. 1 sent. 1 no. 5 in connection with sent. 2 WpHG (Name of shareholders holding directly 3% voting rights or more which are attributed to the notifier: Paulson & Co. Inc.). In addition, J.P. Morgan Broker-Dealer Holdings Inc., New York, USA, notified us on 29 January 2013 pursuant to section 21 para. 1 WpHG of the following: On 24 January 2013 J.P. Morgan Broker-Dealer Holdings Inc. exceeded the threshold of 3% of the voting rights in RHÃN-KLINIKUM AG, Schlossplatz 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date J.P. Morgan Broker-Dealer Holdings Inc. held 4.27% of the voting rights in RHÃN-KLINIKUM AG arising from 5,895,660 voting rights. These voting rights in RHÃN-KLINIKUM AG are completely attributed to J.P. Morgan Broker-Dealer Holdings Inc. pursuant to sec. 22 para. 1 sent. 1 no. 5 in connection with sent. 2 WpHG (Name of shareholders holding directly 3% voting rights or more which are attributed to the notifier: Paulson & Co. Inc.). In addition, J.P. Morgan Securities LLC, New York, USA notified us on 29 January 2013 pursuant to section 21 para. 1 WpHG of the following: On 24 January 2013 J.P. Morgan Securities LLC exceeded the threshold of 3% of the voting rights in RHÃN-KLINIKUM AG, Schlossplatz 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date J.P. Morgan Securities LLC held 4.27% of the voting rights in RHÃN-KLINIKUM AG arising from 5,895,660 voting rights. These voting rights in RHÃN-KLINIKUM AG are completely attributed to J.P. Morgan Securities LLC pursuant to sec. 22 para. 1 sent. 1 no. 5 in connection with sent. 2 WpHG (Name of shareholders holding directly 3% voting rights or more which are attributed to the notifier: Paulson & Co. Inc.). In addition, J.P. Morgan Clearing Corp., Brooklyn/New York, USA, notified us on 29 January 2013 pursuant to section 21 para. 1 WpHG of the following: On 24 January 2013 J.P. Morgan Clearing Corp. exceeded the threshold of 3% of the voting rights in RHÃN-KLINIKUM AG, Schlossplatz 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date J.P. Morgan Clearing Corp. held 4.27% of the voting rights in RHÃN-KLINIKUM AG arising from 5.895.660 voting rights. These voting rights in RHÃN-KLINIKUM AG are completely attributed to J.P. Morgan Clearing Corp. pursuant to sec. 22 para. 1 sent. 1 no. 5 (Name of shareholders holding directly 3% voting rights or more which are attributed to the notifier: Paulson & Co. Inc.). Bad Neustadt a. d. Saale, 30 January 2013 The Board of Management Dr. Kai G. Klinger Head of Investor Relations RHÃN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a. d. Saale Phone: +49 9771 65 - 1318 Fax: +49 9771 99 - 1736 30.01.2013 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: RHÃN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a.d.Saale Germany Internet: www.rhoen-klinikum-ag.com End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-PVR: RHÃN-KLINIKUM AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
| Source: EQS Group AG